Researchers at the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) have developed PEDRA: Platform for Ex-Vivo Drug Response Assays. Up to 100 compounds are tested in parallel on primary patient-derived cells using High Content...

It’s 2025 and a growing number of pathologists is already convinced, that going digital is worth it. (If you’re still on the fence, read our Ultimate Guide: 10 Things You Should Know about the Transformational Impact of Digital Pathology). One...

To advance the development of innovative driver monitoring systems, it is essential to acquire multimodal data that includes driving behavior, driver states, well-being, and cognitive load. However, to achieve high-quality studies, robust...

The Laboratory for Bio-Micro Devices at Brigham and Women’s Hospital () develops drug releasing implantable intratumoral microdevices (IMD) [1]. Using MIKAIA®, they want to examine in a quantitative fashion how the cell subpopulations change...

Tomorrow’s healthcare isn’t just about the transformation into a fully digitized and interconnected system; it’s also about nurturing, approving, and implementing innovative digital medical products. To gain market approval, innovators must...